Search

Erica S Y Lin

Examiner (ID: 4581, Phone: (571)270-7911 , Office: P/2853 )

Most Active Art Unit
2853
Art Unit(s)
2853, 2861
Total Applications
1103
Issued Applications
882
Pending Applications
99
Abandoned Applications
155

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17822705 [patent_doc_number] => 11427643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Targeted protein degradation [patent_app_type] => utility [patent_app_number] => 16/879896 [patent_app_country] => US [patent_app_date] => 2020-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 16959 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16879896 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/879896
Targeted protein degradation May 20, 2020 Issued
Array ( [id] => 18412114 [patent_doc_number] => 11666641 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-06-06 [patent_title] => CRISPR nuclease [patent_app_type] => utility [patent_app_number] => 17/594761 [patent_app_country] => US [patent_app_date] => 2020-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 23807 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594761 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/594761
CRISPR nuclease Apr 29, 2020 Issued
Array ( [id] => 17207751 [patent_doc_number] => 11168110 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-11-09 [patent_title] => Method for separation of monomeric polypeptides from aggregated polypeptides [patent_app_type] => utility [patent_app_number] => 16/851458 [patent_app_country] => US [patent_app_date] => 2020-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10988 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16851458 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/851458
Method for separation of monomeric polypeptides from aggregated polypeptides Apr 16, 2020 Issued
Array ( [id] => 17968259 [patent_doc_number] => 11485773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-11-01 [patent_title] => Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria [patent_app_type] => utility [patent_app_number] => 16/818631 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 30 [patent_no_of_words] => 11950 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818631 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818631
Protease inhibitor:protease sensitive expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria Mar 12, 2020 Issued
Array ( [id] => 17845118 [patent_doc_number] => 11434474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-06 [patent_title] => Modulation of lipid metabolism for protein production [patent_app_type] => utility [patent_app_number] => 16/818162 [patent_app_country] => US [patent_app_date] => 2020-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 32 [patent_no_of_words] => 28719 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16818162 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/818162
Modulation of lipid metabolism for protein production Mar 12, 2020 Issued
Array ( [id] => 17742831 [patent_doc_number] => 11390888 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-19 [patent_title] => Methods for genomic integration [patent_app_type] => utility [patent_app_number] => 16/816172 [patent_app_country] => US [patent_app_date] => 2020-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 36 [patent_no_of_words] => 38850 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16816172 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/816172
Methods for genomic integration Mar 10, 2020 Issued
Array ( [id] => 16500064 [patent_doc_number] => 10865441 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Mutant Taq polymerase for faster amplification [patent_app_type] => utility [patent_app_number] => 16/813425 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8964 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 214 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813425 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813425
Mutant Taq polymerase for faster amplification Mar 8, 2020 Issued
Array ( [id] => 16204892 [patent_doc_number] => 20200237882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-30 [patent_title] => Compositions and Methods for Treating Pathological Calcification and Ossification [patent_app_type] => utility [patent_app_number] => 16/813315 [patent_app_country] => US [patent_app_date] => 2020-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25825 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16813315 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/813315
Compositions and methods for treating pathological calcification and ossification Mar 8, 2020 Issued
Array ( [id] => 16343967 [patent_doc_number] => 20200308617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => METHODS FOR IMPROVED PRODUCTION OF REBAUDIOSIDE D AND REBAUDIOSIDE M [patent_app_type] => utility [patent_app_number] => 16/799541 [patent_app_country] => US [patent_app_date] => 2020-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34017 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16799541 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/799541
Methods for improved production of Rebaudioside D and Rebaudioside M Feb 23, 2020 Issued
Array ( [id] => 16009381 [patent_doc_number] => 20200179533 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => THYMIDINE KINASE GENE [patent_app_type] => utility [patent_app_number] => 16/798198 [patent_app_country] => US [patent_app_date] => 2020-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -63 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798198 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/798198
Thymidine kinase gene Feb 20, 2020 Issued
Array ( [id] => 17133150 [patent_doc_number] => 11134681 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-10-05 [patent_title] => Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing [patent_app_type] => utility [patent_app_number] => 16/785870 [patent_app_country] => US [patent_app_date] => 2020-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 19107 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785870 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/785870
Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Feb 9, 2020 Issued
Array ( [id] => 16238577 [patent_doc_number] => 20200255811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-08-13 [patent_title] => PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER [patent_app_type] => utility [patent_app_number] => 16/783841 [patent_app_country] => US [patent_app_date] => 2020-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10027 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16783841 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/783841
PHOSPHOTRIESTERASE ENZYME TETHERED MONOMER Feb 5, 2020 Abandoned
Array ( [id] => 16525538 [patent_doc_number] => 20200399618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-12-24 [patent_title] => Compositions and Methods for Pesticide Degradation [patent_app_type] => utility [patent_app_number] => 16/778653 [patent_app_country] => US [patent_app_date] => 2020-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -25 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16778653 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/778653
Compositions and Methods for Pesticide Degradation Jan 30, 2020 Abandoned
Array ( [id] => 15931765 [patent_doc_number] => 20200157516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-21 [patent_title] => PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS [patent_app_type] => utility [patent_app_number] => 16/752887 [patent_app_country] => US [patent_app_date] => 2020-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43640 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752887 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/752887
PEPTIDE-MEDIATED DELIVERY OF RNA-GUIDED ENDONUCLEASE INTO CELLS Jan 26, 2020 Abandoned
Array ( [id] => 17664156 [patent_doc_number] => 11357832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase [patent_app_type] => utility [patent_app_number] => 16/744140 [patent_app_country] => US [patent_app_date] => 2020-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27696 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744140 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744140
Treatment of cognitive impairment of hunter syndrome by intrathecal delivery of iduronate-2-sulfatase Jan 14, 2020 Issued
Array ( [id] => 17088626 [patent_doc_number] => 11116796 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Nanoparticle formulations [patent_app_type] => utility [patent_app_number] => 16/742082 [patent_app_country] => US [patent_app_date] => 2020-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 21044 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 299 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16742082 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/742082
Nanoparticle formulations Jan 13, 2020 Issued
Array ( [id] => 15899011 [patent_doc_number] => 20200149024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => Engineered CRISPR-Cas9 Nucleases [patent_app_type] => utility [patent_app_number] => 16/734935 [patent_app_country] => US [patent_app_date] => 2020-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20338 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -41 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16734935 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/734935
Engineered CRISPR-Cas9 nucleases Jan 5, 2020 Issued
Array ( [id] => 15769435 [patent_doc_number] => 20200115735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => NOVEL LUCIFERASE SEQUENCES UTILIZING INFRARED-EMITTING SUBSTRATES TO PRODUCE ENHANCED LUMINESCENCE [patent_app_type] => utility [patent_app_number] => 16/725586 [patent_app_country] => US [patent_app_date] => 2019-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16725586 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/725586
Luciferase sequences utilizing infrared-emitting substrates to produce enhanced luminescence Dec 22, 2019 Issued
Array ( [id] => 16175546 [patent_doc_number] => 20200222514 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-16 [patent_title] => CARBAPENEMASES FOR USE WITH ANTIBIOTICS FOR THE PROTECTION OF THE INTESTINAL MICROBIOME [patent_app_type] => utility [patent_app_number] => 16/720999 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 46599 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720999 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/720999
Carbapenemases for use with antibiotics for the protection of the intestinal microbiome Dec 18, 2019 Issued
Array ( [id] => 17029576 [patent_doc_number] => 11091380 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-17 [patent_title] => Composition and methods of use [patent_app_type] => utility [patent_app_number] => 16/707367 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 12 [patent_no_of_words] => 14083 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16707367 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/707367
Composition and methods of use Dec 8, 2019 Issued
Menu